Basil Hirschowitz

Basil Hirschowitz's AcademicInfluence.com Rankings

Basil Hirschowitz

Philosophy

#6073

World Rank

#9044

Historical Rank

Logic

#3370

World Rank

#4517

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Basil Hirschowitz's Degrees

Doctorate Medicine University of Cape Town

Why Is Basil Hirschowitz Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Basil Isaac Hirschowitz was an academic gastroenterologist from the University of Alabama at Birmingham best known in the field for having invented an improved optical fiber which allowed the creation of a useful flexible endoscope. This invention revolutionized the practice of gastroenterology and also was a key invention in optical fiber communication in multiple industries.

(See a Problem?)

Basil Hirschowitz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Association of obesity with hiatal hernia and esophagitis (1999) (383)
Surgery to cure the Zollinger-Ellison syndrome. (1999) (253)
Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. (1992) (215)
A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. (1991) (213)
Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. (1992) (178)
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. (1992) (176)
Quantitative ultrastructural studies on gastric parietal cells. (1972) (172)
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. (1994) (145)
Endoscopic examination of the stomach and duodenal cap with the fiberscope. (1961) (133)
Vagal gastric secretory stimulation by 2-deoxy-D-glucose. (1965) (131)
Vitamin B12 deficiency in hypersecretors during long‐term acid suppression with proton pump inhibitors (2008) (103)
Pepsinogen: its origins, secretion and excretion. (1957) (92)
Risk factors for isoniazid (NIH)-induced liver dysfunction. (1981) (87)
Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. (1979) (78)
H-2 histamine receptors. (1979) (76)
A personal history of the fiberscope. (1979) (71)
An 125I radioimmunoassay for primary conjugated bile salts. (1977) (69)
Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13-year prospective study. (2005) (66)
Vagal stimulation of gastric secretion in man by 2-deoxy-D-glucose. (1965) (66)
Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. (1976) (63)
Significant role of aspirin use in patients with esophagitis. (1991) (62)
Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog. (1983) (60)
Quantitative ultrastructural studies on inhibited and on partly stimulated gastric parietal cells. (1974) (57)
Properties of ATPase of gastric mucosa. 3. Distribution of HCO 3 -stimulated ATPase in gastric mucosa. (1972) (53)
Pharmacological aspects of acid secretion (1995) (52)
Studies on adenyl cyclase in Necturus gastric mucosa. (1971) (50)
Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes. (1988) (50)
Suppression of Lymphocyte Transformation by 16, (16) Dimethyl Prostaglandin E2 and Unsaturated Fatty Acids 1 (1975) (49)
Helicobacter pylori effects on gastritis, gastrin and enterochromaffin‐like cells in Zollinger–Ellison syndrome and non‐Zollinger–Ellison syndrome acid hypersecretors treated long‐term with lansoprazole (2001) (48)
Preliminary report on a long fiberscope for examination of stomach and duodenum. (1957) (45)
Toxicity of NSAIDs in the stomach and duodenum. (1999) (44)
Long‐term treatment with lansoprazole for patients with Zollinger–Ellison syndrome (1996) (43)
CONTROVERSIES IN THE DETECTION AND MANAGEMENT OF NONSTEROIDAL ANTIINFLAMMATORY DRUG‐INDUCED SIDE EFFECTS OF THE UPPER GASTROINTESTINAL TRACT (1989) (43)
Pepsinogen in the blood. (1955) (43)
Duodenal ulcer with unexplained marked basal gastric acid hypersecretion. (1980) (42)
Acetyl phosphatase in brain microsomes: A partial reaction of Na+ + K+ ATPase☆ (1967) (41)
Relation of gastric acid and pepsin secretion to serum gastrin levels in dogs given bombesin and gastrin-17. (1983) (41)
Intractable upper gastrointestinal ulceration due to aspirin in patients who have undergone surgery for peptic ulcer. (1998) (40)
Gastroduodenal endoscopy with the fiberscope--an analysis of 500 examinations. (1962) (40)
Long‐term lansoprazole control of gastric acid and pepsin secretion in ZE and non‐ZE hypersecretors: a prospective 10‐year study (2001) (40)
Atropine inhibition of insulin-, histamine-, and pentagastrin-stimulated gastric electrolyte and pepsin secretion in the dog. (1969) (38)
Aspirin related gastrointestinal bleeders have an exaggerated bleeding time response due to aspirin use. (1996) (38)
Bone metastases in malignant gastrinoma. (1986) (38)
Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls (1996) (38)
Double lumen esophagus due to reflux esophagitis with fibrous septom formation. (1976) (36)
A FIBRE OPTIC FLEXIBLE CESOPHAGOSCOPE. (1963) (36)
Clinical Course of Nonsurgically Treated Zollinger-Ellison Syndrome (1994) (36)
Influence of smoking on basal and on vagally and maximally stimulated gastric acid and pepsin secretion. (1992) (35)
Frog Gastric Mucosal ATPase.∗ (1965) (34)
Pure red cell aplasia and protein-losing enteropathy in a patient with systemic lupus erythematosus. (1985) (33)
Zollinger-Ellison syndrome: presentation, response to therapy, and outcome. (2011) (31)
Development and application of endoscopy. (1993) (30)
The energy source for gastric H+ secretion. (1968) (29)
Ranitidine suppression of gastric hypersecretion resistant to cimetidine. (1982) (28)
Electrical properties of isolated cells of Necturus gastric mucosa. (1971) (27)
Within-day fluctuations in serum bile-acid concentrations among normal control subjects and patients with hepatic disease. (1980) (27)
Urinary excretion of pepsinogen in gastroduodenal ulceration. (1953) (26)
Atypical and Aggressive Upper Gastrointestinal Ulceration Associated With Aspirin Abuse (2002) (25)
Natural history of duodenal ulcer. (1983) (24)
Atropine suppresses gastrin release by food intact and vagotomized dogs. (1981) (23)
Comparison of actions of aminophylline and pentagastrin on Necturus gastric mucosa. (1970) (22)
Heterogeneity of 3',5'-phosphodiesterase of gastric mucosa. (1972) (22)
Portal hypertension, congestive splenomegaly, and portacaval shunt. (1962) (22)
Inhibition of gastric secretion in the dog by 16,16-dimethyl prostaglandin E2. (1976) (22)
ALPHA1-ANTITRYPSIN AND CHRONIC PANCREATITIS (1976) (22)
Hypomagnesemia with tetany in nontropical sprue. (1961) (21)
Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells. (1988) (21)
Histamine dose responses in gastric fistula dogs--decreasing secretion with time. (1968) (21)
Utilization of a radioiodinated bile salt for kinetic studies and hepatic scintigraphy. Studies in nonhuman mammals. (1979) (21)
Pyogenic Liver Abscess: A Review with a Case Report of a Solitary Abscess Caused by Salmonella Enteriditis (1952) (21)
Apparent kinetics of histamine dose-responsive gastric water and electrolyte secretion in the dog. (1968) (21)
Hepatitis B antigen and antibody and tests of liver function: a prospective study of 310 hospital laboratory workers. (1980) (20)
Postnatal physiologic hypercholemia in both premature and full-term infants. (1981) (19)
A critical evaluation of a procedure for measurement of serum bile acids by radioimmunioassay. (1977) (19)
Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy (2000) (19)
Risk factors for esophagitis in extreme acid hypersecretors with and without Zollinger-Ellison syndrome. (2004) (18)
Reversible prolonged skin bleeding time in acute gastrointestinal bleeding presumed due to NSAIDs. (1996) (18)
Effects of cholinergic, histaminergic, and peptidergic stimulation on pepsinogen secretion by isolated human peptic cells. (1994) (18)
Electrolytes in human gastric secretion (1961) (18)
Ingestion of aspirin prevents platelet-induced human fibroblast growth. Implications for peptic ulcer healing. (1994) (18)
The Search for Submammalian Gastrins: The Identification of Amphibian Gastrin 1 (1976) (17)
Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. (1984) (17)
Action of 2-deoxy-D-glucose on frog gastric mucosa. (1965) (17)
Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management. (1997) (17)
U.S. experience with omeprazole in duodenal ulcer (1991) (17)
Bombesin, neuromedin B and neuromedin C interact with a common rat pancreatic phosphoinositide-coupled receptor, but are differentially regulated by guanine nucleotides. (1991) (17)
Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia (2007) (16)
Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome. (1978) (16)
The action of amytal on frog gastric mucosa. (1967) (16)
Divergent effects of bombesin and bethanechol on stimulated gastric secretion in duodenal ulcer and in normal men. (1987) (16)
Inhibition of Basal Acid, Chloride, and Pepsin Secretion in Duodenal Ulcer by Graded Doses of Ranitidine and Atropine with Studies of Pharmacokinetics of Ranitidine (1982) (16)
Pentagastrin in the gastric fistula dog. (1969) (16)
Effect of Therapeutic Doses of Colchicine on Oxidative Enzymes in the Intestine (1964) (15)
Dose dependence of insulin-stimulated gastric secretion (1964) (15)
Evaluation of two commercial kits for serum gastrin assay, and comparison with a conventional radioimmunoassay procedure. (1977) (15)
Purification and characterization of a liver-specific antigen. (1976) (15)
Pepsinogen secretion from perifused frog peptic glands: rapid transients detected with a modified pepsin assay. (1988) (15)
Lessons from The U.S. Multicenter Trial of Ranitidine Treatment for Duodenal Ulcer (1983) (14)
Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin. (1990) (14)
Analysis of food stimulation of gastrin release in dogs by a panel of inhibitors (1984) (14)
Insulin inhibition of gastric secretion: reversal by ribidium. (1967) (14)
Radiolabelled bile acid clearance in control subjects and patients with liver disease. (1979) (14)
Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls (1993) (14)
Endoscopy in the post-gastrectomy patient. An analysis of 580 patients. (1971) (14)
Aneurysm of the abdominal aorta with a report of four unusual cases. (1951) (13)
NSAID association with gastrointestinal bleeding and peptic ulcer. (1991) (13)
Histamine h-2 receptor antagonists. (1977) (13)
Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. (1996) (13)
Zollinger-Ellison syndrome unresponsive to cimetidine. (1979) (13)
A Multicenter Study of Ranitidine Treatment of Duodenal Ulcers in the United States (1986) (12)
Disordered esophageal motility in Wilson's disease. (1980) (12)
Comparison of 13C- urea blood test to 13C-breath test and rapid urease test for the diagnosis of Helicobacter pylori infection. (2005) (12)
Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls (1996) (12)
Endoscopy – 40 Years since Fiber Optics (2000) (12)
Effects of four H2 histamine antagonists on bethanechol-stimulated acid and pepsin secretion in the dog. (1983) (12)
Synergism between cellular messengers and agonist combinations in pepsinogen secretion. (1987) (11)
Autonomous cholesterol biosynthesis in murine hepatoma. A receptor defect with normal coated pits (1984) (11)
Control of pepsinogen secretion (1991) (11)
Effect of irreversible inhibitors on transport ATPase. (1969) (11)
Treatment strategies for Zollinger-Ellison syndrome. (2009) (11)
The development and application of fiberoptic endoscopy (1988) (11)
Development of sustained achlorhydria in a patient with the Zollinger-Ellison syndrome treated with omeprazole. (1991) (10)
Action of thiocyanate on gastric mucosa in vitro. (1969) (10)
Clinical aspects of ECL-cell abnormalities. (1998) (10)
Secretion by Guinea Pig Gastric Mucosa in vitro ∗ (1966) (10)
The cost of doing business: occupational hazards for endoscopists. (1994) (10)
Treatment strategies for Zollinger–Ellison syndrome (2009) (10)
Early fiberscope endoscopy for upper gastrointestinal bleeding (1963) (10)
Questions regarding future research on aspirin and the gastrointestinal tract. (2001) (10)
Pepsin and the esophagus. (1999) (10)
A unique "mini" pepsinogen isolated from bullfrog esophageal glands. (1982) (10)
Long-term effects of highly selective vagotomy (HSV) in dogs on acid and pepsin secretion (1977) (10)
Inhibition of basal acid, chloride, and pepsin secretion in duodenal ulcer by graded doses of ranitidine and atropine with studies of pharmacokinetics of ranitidine. (1982) (9)
Acid and pepsin secretion in patients with esophagitis refractory to treatment with H2 antagonists. (1992) (9)
Histamine H-2 receptor stimulation and inhibition of pepsin secretion in the dog. (1981) (9)
Hormonal stimulation of Necturus gastric mucosa in vitro. (1967) (9)
Determination of the pool size and synthesis rate of bile acids by measurements in blood of patients with liver disease. (1980) (9)
Pepsinogen. (1984) (9)
Photography through the fiber gastroscope (1963) (9)
Absence of gastrointestinal infections in a cohort of patients with Zollinger-Ellison syndrome and other acid hypersecretors receiving long-term acid suppression with lansoprazole (2008) (9)
Use of impromidine to define specific histamine H-2 effects on gastric secretion, heart rate and blood pressure in conscious dogs. (1980) (8)
Effect of tranexamic acid on gastric bleeding in rats. (1988) (8)
Bombesin and G-17 dose responses in duodenal ulcer and controls (1985) (8)
Restoration of homeostasis during histamine-stimulated gastric secretion by rapid intravenous injection of KCl. (1968) (8)
Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy. (2000) (8)
Long-term penicillamine therapy for Wilson's disease. (1980) (8)
Controls of gastric secretion. A roadmap to the choice of treatment for duodenal ulcer. (1982) (7)
Somatostatin, prostaglandin E2 and atropine inhibition of the gastric actions of bombesin in the dog (1984) (7)
Kinetics of atropine inhibition of pentagastrin-stimulated H+, electrolyte, and pepsin secretion in the dog (1977) (7)
Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies. (1988) (7)
The effect of hydroxylamine on transport ATPase. (1971) (7)
Gastric and cardiac H-2 receptor effects of dimaprit and N'(Me),5(Me)histamine in conscious dogs. (1980) (7)
Decreased secretion due to a Ca2+ influx defect in frog peptic cells isolated with EGTA. (1990) (7)
KCl reversal of insulin inhibition and fade in pentagastrin-stimulated gastric secretion. (1972) (7)
The role of Ca2+ in the time-dependent pepsinogen secretion of frog oesophageal peptic glands stimulated by bombesin. (1990) (7)
THE MANAGEMENT OF PEPTIC ULCER (1945) (7)
Homeostatic consequences of gastric water, acid, and electrolyte secretion in the dog. (1968) (6)
Neural and Hormonal Control of Gastric Secretion (2011) (6)
Anticholinergic potency of diphenhydramine (Benadryl) measured against bethanechol in the gastric fistula dog. (1983) (6)
Gastrin I, pentagastrin and histamine in the fistula dog. (1968) (6)
Histamine H1 and H2 effects on gastric acid and pepsin, heart rate and blood pressure in humans. (1984) (6)
Nonsteroidal anti-inflammatory drugs and the gut. (1996) (6)
Marginal Ulcer in Achlorhydric Patients (1975) (6)
Somatostatin effects on gastric electrolytes and pepsin in dogs with various secretory stimuli. (1987) (5)
Early gastric cancer (1976) (5)
Treatment of Benign Chronic Gastric Ulcer with Ranitidine: A Randomized, Double‐blind, and Placebo‐Controlled Six Week Trial (1986) (5)
Progress in Esophagoscopy (1970) (5)
Historical perspectives on technology in GI endoscopy (2003) (5)
Presentation, response to lansoprazole therapy, and outcome of Zollinger–Ellison syndrome-like gastric acid hypersecretors (2011) (5)
Endoscopy--40 years since fiber optics. Any light at the end of the tunnel? (2000) (5)
Effects of colchicine on intestinal mucosal dehydrogenases (1966) (5)
Direct inhibition of gastric electrolyte secretion by insulin, independent of hypoglycemia or the vagus (1966) (5)
Synthesis and secretion of pepsinogen in the rat; effects of alteration of adrenal activity and of body hydration. (1959) (5)
Characteristics of inhibition of gastric electrolyte secretion by insulin (1966) (5)
Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long‐term treatment in ZE and non‐ZE acid hypersecretors (2002) (5)
Double-barrel gastrojejunal stoma and its symptoms and complications in 38 patients. (1971) (5)
Reversal of insulin inhibition of gastric secretion by intravenous injection of potassium (1966) (5)
Pyogenic liver abscess: a review with a case report of a solitary abscess caused by Salmonella enteritidis. (1952) (4)
A highly active gastric secretagogue extracted from a metastasis of a zollinger-ellison tumor (1963) (4)
Twenty-three patients with Mallory-Weiss syndrome. (1970) (4)
Usual and unusual causes of duodenal ulcer. (2003) (4)
Diagnosis by Gastrophotography (1972) (4)
Cimetidine for prevention of acute gastrointestinal bleeding. (1980) (4)
Medical management of esophageal reflux. (1994) (4)
Effects of colchicine on intestinal mucosal dehydrogenases. II. Biochemical observations. (1966) (4)
VITAMIN B12 AND THE SO-CALLED ANTIBIOTIC DEFICIENCY SYNDROMES (1953) (4)
Inhibition of gastric acid secretion in vitro by C-terminal octapeptide of cholecystokinin. (1971) (4)
Costs and Risks in the Management of Patients With Gastric Acid Hypersecretion (2010) (4)
Effects of burimamide, an antagonist of H-2 histamine receptors, in the gastric fistula dog (1974) (4)
Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome. (1992) (4)
Correlation of lower esophageal sphincter pressure and serum gastrin level in man (1975) (4)
Histamine and the gut. (1985) (3)
Somatostatin and lanthanum discriminate two Ca2+ mobilizing mechanisms regulated by bombesin receptors in peptic cells. (1989) (3)
Effect of cimetidine on histamine-stimulated gastric acid and electrolytes in dogs. (1983) (3)
Influence of atropine on resistance, potential, and H+ secretion in isolated gastric mucosa. (1970) (3)
Radioimmunoassay of Serum Bile Acid Levels in Biopsy‐Proved Cirrhosis (1977) (3)
Effects of very low doses of atropine on basal acid and pepsin secretion, gastrin, and heart rate in normals and DU (1984) (3)
Alpha-antitrypsin and chronic pancreatitis. (1976) (3)
Muscarinic receptor antagonist activity of diacylglycerol lipase and kinase inhibitors. (1990) (3)
Acetaminophen and hepatic necrosis. (1977) (3)
Gastroduodenal endoscopy with the fiberscope. (1962) (3)
Classification of the post-gastrectomy syndromes based on observation of 580 patients. (1971) (2)
Esophagitis in ZE and non-ZE patients with acid hypersecretion (BAO > 15 mM/h) treated prospectively for up to 10 yr. with lansoprazole (2000) (2)
History of fiberoptic endoscopy (1980) (2)
125I-iodopindolol binding to frog esophageal peptic cells. Detection of amine uptake and beta-adrenergic receptors coupled to pepsinogen secretion. (1989) (2)
Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats. (1988) (2)
USE OF MOTION PICTURES IN TEACHING & DIAGNOSIS * (1967) (2)
Management of refractory and complicated reflux esophagitis. (1996) (2)
Clinical outcome with long-term (up to 10 yr.) lansoprazole treatment of acid hypersecretors (BAO > 15 mM/h) (ZE and non-ZE) — role of acid, pepsin and H. pylori (2000) (2)
In vitro studies of Anti-Inflammatory agents and prostaglandin e2 effects on stimulated normal human fibroblast cultures (1994) (2)
Cirrhosis Following Prolonged Treatment of Psoriasis with Methotrexate Orally (1972) (2)
An update on histamine receptors and the gastrointestinal tract (1985) (2)
An upside-down view of an upside-down organ: endoscopic appearance in paraesophageal hiatus hernia. (1977) (2)
Effects of colchicine on intestinal mucosal dehydrogenases (2005) (2)
Quantitation of inhibition of gastric electrolyte secretion by insulin in the dog. (1966) (2)
Sensitivity of serum glutamic oxaloacetic transaminase and bile acid levels for the detection of experimental liver injury in rats. (1981) (2)
A plea for clarity. (1981) (2)
A History of Gastric Secretion and Digestion: Experimental Studies to 1975, H.W. Davenport. Oxford University Press (1992), 401 pp., $75.00 (1993) (2)
Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat. (1982) (2)
Inhibition of basal and stimulated gastric H+ and pepsin secretion in duodenal ulcer patients by metiamide, an H-2 histamine antagonist (1976) (1)
Comparison of 13C urea breath and blood tests for H. pylori (1998) (1)
SPIRONOLACTONE AND SERUM-BILE-SALT LEVELS (1977) (1)
Color Atlas of Endoscopy and Biopsy of the Intestine (1976) (1)
Benign duodenal gastrinoma associated with the Zollinger-Ellison syndrome. (1977) (1)
SERUM-BILE-ACIDS IN INFLAMMATORY BOWEL DISEASE (1977) (1)
Measurement of plasma osmolality. (1971) (1)
Gastrin release in fistula dogs with solid compared to nutrient and nonnutrient liquid meals (1983) (1)
An H 1 type histamine action which causes cardiac deceleration in the intact dog (1977) (1)
Silicones in experimental peptic ulceration (1960) (1)
Group-specific component [Gc] levels in chronic liver disease. (1978) (1)
Action of SCN- on Rat Liver Mitochondria 1 (1970) (1)
Stimuli of pepsinogen secretion from frog isolated peptic cells (1986) (1)
Modification of D-galactosamine-induced liver injury in the rat by spironolactone. (1979) (1)
Continuing gastric secretion after insulin hypoglycemia despite glucose injection (2005) (1)
Gastric acid secretion (1976) (1)
Gastrointestinal endoscopy for surgeons: Edited by R. K. Pearl. 190 pp., $29.95. Little, Brown & Company, Boston, Massachusetts and Toronto, Canada, 1985 (1986) (1)
Insulin effects on gastric secretion and blood electrolytes modified by injected potassium (2005) (1)
Familial nonhemolytic jaundice with free and conjugated hyperbilirubinemia, elevated serum bile acids, and liver pigmentation. (1979) (1)
Serum lysozyme activity in inflammatory bowel disease. (1978) (1)
Editorial: Early gastric cancer. (1976) (1)
Therapeutic trial of silicone in peptic ulcer (1960) (1)
Bombesin stimulation of gastrin release in duodenal ulcer (DU) & Zollinger-Ellison syndrome (ZES) (1980) (0)
Death notices (2011) (0)
PROTRACTED LABOUR. (1963) (0)
[Non-steroid anti-inflammatory agents and digestive tract lesions]. (1993) (0)
Murine Hepatitis Virus: Effect on Liver RNA (1968) (0)
Antigenic Properties of Subcellular Fractions from Canine Pancreas: Development of a Zymogen Membrane Specific Antibody 1 (1975) (0)
PREOPERATIVE SKIN PREPARATION. (1963) (0)
Gastrointestinal endoscopy for surgeons (1986) (0)
Steatorrhea and Absent Gastric Antral Motility in Three Female Siblings with Familial Deafness. (1968) (0)
Sclerosing cholangitis associated with ulcerative colitis. Light and electron microscopy studies. (1978) (0)
A simple guard for the fiberscope. (1968) (0)
Zollinger-Ellison syndrome : Pathogenesis, diagnosis, and management. Discussion (1997) (0)
Fiberoptics and research in the last 25 years. (1980) (0)
Pernicious anemia and stomach cancer. (2001) (0)
Towards a rational treatment of duodenal ulcer. (1984) (0)
Use of motion pictures in teaching and diagnosis. (1967) (0)
Surgical endoscopy: By T. L. Dent, W. E. Strodel, and J. G. Turcotte. 536 pp., $59.95. Year Book Medical Publishers, Inc., Chicago, Illinois, 1985 (1986) (0)
Acetyl phosphatase in brain microsomes: a partial reaction of Na+ plus K+ ATPase. (1967) (0)
Endoscopic diagnosis in gastroenterology: Edited by Tatsuzo Kasugai. 292 pp., $85.00. Igaku-Shoin Medical Publishers, Inc., New York, New York, 1982 (1983) (0)
Neurological abnormalities and thrombocytopenia in a young white male. (1988) (0)
Gastric and cardiovascular effects of histamine in the dog (1979) (0)
Protective effects of Alpha-tocopherol on the hepatotoxicity of D-galactosamine. (1976) (0)
Minimizing the risk of NSAID-induced GI bleeding. (1999) (0)
Gastrin release by bombesin & other stimuli in the fistula dog (1980) (0)
Endoscopic diagnosis in gastroenterology (1983) (0)
Presentation of the Julius Friedenwald Medal to Basil I. Hirschowitz, M.D. (1992) (0)
Questionnaire for Trial Submission (2000) (0)
Invited commentary (2005) (0)
Hormonal control of parietal cell function. Invited commentary. (1979) (0)
Receptors and the Upper GI Tract (1983) (0)

This paper list is powered by the following services:

Other Resources About Basil Hirschowitz

en.wikipedia.org

What Schools Are Affiliated With Basil Hirschowitz?

Basil Hirschowitz is affiliated with the following schools:

Basil Hirschowitz's Academic­Influence.com Rankings